In this study, blocking HAMP action by its antagonist Fursultiamine (46) moderately ameliorated Sorafenib-induced cell death, indicating that Sorafenib-induced HAMP expression might be involved in its cytotoxic effect on liver cancer cells (47). This evidence concerns the gene HAMP and liver cancer.